Cite
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.
MLA
Hyung, Jaewon, et al. “Thiotepa, Busulfan, and Cyclophosphamide or Busulfan, Cyclophosphamide, and Etoposide High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Consolidation of Primary Central Nervous System Lymphoma.” Annals of Hematology, vol. 98, no. 7, July 2019, pp. 1657–64. EBSCOhost, https://doi.org/10.1007/s00277-019-03667-1.
APA
Hyung, J., Hong, J. Y., Yoon, D. H., Kim, S., Park, J. S., Park, C., Lee, S., Kim, J. H., Ryu, J. S., Huh, J., & Suh, C. (2019). Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma. Annals of Hematology, 98(7), 1657–1664. https://doi.org/10.1007/s00277-019-03667-1
Chicago
Hyung, Jaewon, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-sik Park, Sang-wook Lee, et al. 2019. “Thiotepa, Busulfan, and Cyclophosphamide or Busulfan, Cyclophosphamide, and Etoposide High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Consolidation of Primary Central Nervous System Lymphoma.” Annals of Hematology 98 (7): 1657–64. doi:10.1007/s00277-019-03667-1.